Understanding Schwann cell-neurone interactions: The key to Charcot-Marie-Tooth disease?

Journal of Anatomy

Volumn 200, Issue 4, 2002, Pages 357-366

  Maier, Marcel ^a   Berger, Philipp ^a   Suter, Ueli ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Charcot Marie Tooth disease; Schwann cells

Indexed keywords

MYELIN PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CELL INTERACTION; CONTROLLED STUDY; GENE DOSAGE; GENE EXPRESSION; GENE MUTATION; GENETIC CODE; HEREDITARY MOTOR SENSORY NEUROPATHY; MISSENSE MUTATION; MOUSE; NERVE CELL; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SCHWANN CELL;

ANIMALS; AXONS; CELL COMMUNICATION; CHARCOT-MARIE-TOOTH DISEASE; DISEASE PROGRESSION; HUMANS; MODELS, ANIMAL; MYELIN PROTEINS; NEURONS; SCHWANN CELLS;

ANIMALIA; VERTEBRATA;

EID: 0036247602     PISSN: 00218782     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-7580.2002.00044.x     Document Type: Review

References (83)

1. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice
2. Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy
3. On the molecular architecture of myelinated fibers
4. Differential Cyclin D1 Requirements of proliferating Schwann cells during development and after injury
5. Proliferation of Schwann cells and regulation of cyclin D1 expression in an animal model of Charcot-Marie-Tooth disease type 1
6. Molecular cell biology of Charcot-Marie-Tooth disease
7. Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway
8. Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2
9. Denaturing high-performance liquid chromatography of the myotubularin-related 2 gene (MTMR2) in unrelated patients with Charcot-Marie-Tooth disease suggests a low frequency of mutation in inherited neuropathy
10. The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy
11. The role of macrophages in demyelinating peripheral nervous system of mice heterozygously deficient in PO
12. Axonal phenotype of Charcot-Marie-Tooth disease associated with a mutation in the myelin protein zero gene
13. The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype
14. Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E
15. Hereditary motor and sensory neuropathies
16. Two PDZ domain proteins encoded by the murine periaxin gene are the result of alternative intron retention and are differentially targeted in Schwann cells
17. Schwann cells and oligodendrocytes read distinct signals in establishing myelin sheath thickness
18. Loss of distal axons and sensory Merkel cells and features indicative of muscle denervation in hindlimbs of P0-deficient mice
19. Changes produced by a hypomyelinating neuropathy in muscle and its innervation. Morphological and physiological studies in the Trembler mouse
20. Genetic heterogeneity in autosomal recessive hereditary motor and sensory neuropathy with focally folded myelin sheaths (CMT4B)
21. PO and PMP22 mark a multipotent neural crest-derived cell type that displays community effects in response to TGF-beta family factors
22. Competitive binding of triplex-forming oligonucleotides in the two alternate promoters of the PMP22 gene
23. Ultrastructural distribution of PMP22 in Charcot-Marie-Tooth disease type 1A
24. Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA
25. Myelin disorders
26. Dejerine-Sottas neuropathy in mother and son with same point mutation of PMP22 gene
27. Identification of two new Pmp22 mouse mutants using large-scale mutagenesis and a novel rapid mapping strategy
28. Origin and early development of Schwann cells
29. Schwann cells and their precursors emerge as major regulators of nerve development
30. The peripheral myelin protein 22 and epithelial membrane protein family
31. N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom
32. Charcot-Marie-Tooth disease type 1: Molecular pathogenesis to gene therapy
33. Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A
34. Characterization of the myotubularin dual specificity phosphatase gene family from yeast to human
35. In early development of the rat mRNA for the major myelin protein P (0) is expressed in nonsensory areas of the embryonic inner ear, notochord, enteric nervous system, and olfactory ensheathing cells
36. The early life of a Schwann cell
37. Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage
38. Mouse genetics in cell biology
39. The effect of myelinating Schwann cells on axons
40. Phosphorylation-dependent neurofilament epitopes are reduced at the node of Ranvier
41. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene
42. The neurobiology of Schwann cells
43. An axonal form of Charcot-Marie-Tooth disease showing distinctive features in association with mutations in the peripheral myelin protein zero gene (Thr124Met or Asp75Val)
44. Description of mutations in Cx32 in Italian families with diagnosis of CMT1 and CMT2
45. Cytochemical demonstration of succinic dehydrogenase by the use of a new p-nitrophenyl substituted ditetrazole
46. Many facets of the peripheral myelin protein PMP22 in myelination and disease
47. EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression
48. Altered molecular architecture of peripheral nerves in mice lacking the peripheral myelin protein 22 or connexin32
49. Uncoupling of myelin assembly and schwann cell differentiation by transgenic overexpression of peripheral myelin protein 22
50. Behavioural profiling of a murine Charcot-Marie-Tooth disease type 1A model
51. Giant axonal neuropathy. A review
52. PMP-22 expression in the central nervous system of the embryonic mouse defines potential transverse segments and longitudinal columns
53. Peripheral myelin protein-22 is expressed in rat and mouse brain and spinal cord motoneurons
54. Molecular domains of myelinated axons
55. Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A
56. A new stain for quantitative measurement of sprouting at neuromuscular junctions
57. Development of early postnatal peripheral nerve abnormalities in Trembler-J and PMP22 transgenic mice
58. Effects of PMP22 duplication and deletions on the axonal cytoskeleton
59. Distal axonopathy in peripheral nerves of PMP22-mutant mice
60. Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A
61. Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance
62. A rat transgenic model for Charcot-Marie-Tooth disease
63. A tripartite nuclear localization signal in the PDZ-domain protein L-periaxin
64. Specific disruption of a Schwann cell dystrophin-related protein complex in a demyelinating neuropathy
65. Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13)
66. Molecular anatomy and genetics of myelin proteins in the peripheral nervous system
67. The glycoprotein P0 in peripheral gliogenesis
68. Axon-regulated expression of a Schwann cell transcript that is homologous to a 'growth arrest-specific' gene
69. A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse
70. Trembler mouse carries a point mutation in a myelin gene
71. Biology and genetics of hereditary motor and sensory neuropathies
72. Inaugural article: Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate
73. Membrane topology of peripheral myelin protein 22
74. The phenotypic manifestations of chromosome 17p11.2 duplication
75. Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A
76. Charcot-Marie-Tooth disease type 2
77. Ein Fall von progressiver Muskelatrophie
78. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells
79. Altered neurofilament phosphorylation and beta tubulin isotypes in Charcot-Marie-Tooth disease type 1
80. A myelin protein is encoded by the homologue of a growth arrest-specific gene
81. Disease mechanisms and potential therapeutic strategies in Charcot-Marie-Tooth disease
82. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta
83. Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments